FOXQ1 and invasive breast carcinoma: The results proved that FOXQ1 expression was positively correlated with the stromal and immune score in breast invasive carcinoma, prostate adenocarcinoma, thyroid carcinoma, lung adenocarcinoma, and ovarian serous cystadenocarcinoma.